The informed consent process in cancer research studies. by Coleman, Dorothy A
Cancer Research
Center Hotline
The Informed Consent Process in Cancer
Research Studies
Dorothy L Coleman RN, MS
C’inical Trials Manager,
Cancer Research Center of Hawaii
who rae mr in eareti tuJe is
of paramoune importanc.e. The federal p vermnent has taken the
lead role in e.stahhfeing pr licies and p.roee.dures to ensnrc human
sub Jeetr. prote.e.tlo.n and safety
Current reculations have rot.s in the past, in 1947. the ]Nurr. nihe..rc
-
humane cx pen me t on a I rm filet’ sin ri n \\ oil d
B ar Ii, 1hi Code i a ‘ci in tandarsk ion phxiein and cic1ai’ts
who conduct research on hu.nran subjects, The first prim ipie of the
(ode states th.at volu.ntarv conse.nt is “abso.luteiv e.ssential”, It also
emphasies that consent should he based on the knowledge and
understar idine of the proposed procedures and treatment and the
nossible nsks,
The Dee larar iou f H ci i n Li. wit ten h\ the B rId Heal 111 Orca
uizath n in 1964, nas tarected at medical reeareh ins nix ins human
subjects. it out.1.ined the. specific. topw which should he addre.sse.d
during the. mlormed eottse.nt proees Suhje.ets had to he informe.d,
preferably in writing, f the ai ins and methods of researe h antie.i
pated heuctits and nsk of the study: and nichi of the udu dual to
‘et’use pa’ncipation and to xs thdraw from tlie studs at any lime.5
Follors inc ares Cion tothe Helsinki Declaration, on mIx 1 7. 974.
the National Research Act \Pj\i . signed into law, thereby
creating, the National Comm ssion for the Protee tion of i-I ,mm
Subjects of Biomedical & I3ehavioral Researc.h. Th.is commissIon
yfl5 to idn’trtif’ the basic. e.thieal prlnciptes that should underlie the
ol bmoniediai and behasioral r’eearch iisoh. us human
‘ubiects and to develop stuidelmues to follow to asui’e hat re’earch
I 1 Ii u I_ - 1
Belmont Report s de.veioped
Through the Belmont Report, the NRA dictate.d that all st.udies
using human subjects in. retsearel.i he revie.wed by an institutional
revie.w hoard ([RB hr. flare erants could he ft.tnde.d, Issued in t, 976,
report sumrnani/ed the ha>ic er.hieul princInle fur research, it
er’ses. as a eidelinc form’. ethical :o.ue’ that occur
duin m’esea:eh xs fe human o:hjeets:
The Office of ‘Hu man. R.esearch Protection (OH kIN branch of
the Natiottal institute .sf H.ealth (NIH’). is.’ delegated, by the Se.ere.tar
He.alth and H.uman Services (‘.HHS) to administer pros.trarns fOr
:uN:tntFona] protection of human suhieeo. The Code of Federal
m’s
.,.
-“(,IIs
used a’ , euuelmmte tom’ali ‘e’lton sue. it i evateilt
Beims.ut, Report. Federal ansi ‘tate reptm:’at:omi, along with ethical
and. moral c.ons.:iderati.ons, has’e shaped the informed e.onseiit pro-
‘[‘he process ofobtainmns proper ilornied cmxciii has been the topic
of’ increased attention mit recent rears. Not only clinical researchers,
hut ethieists. lawyers, and social scientists have all become involved
In a constant debate ‘ecanding the informed consent process. The
pact ice of ohtai mm Inc imiformed eonsn’ it dii ldux h’s mi con nt m’s to
eoumttrx end phy’xeian to physician in particular institutions. ‘I’he
most montiati cml :11151 standardiied regulations can he found ii the
[‘mined Statese
Informed consent is defined by the Department of’ Health and
Human Service.s as “the k.nowin.g eonse.nt of an individual or hit.;
legally authortxed t’epresentative so situated as to he able to exem’cise
Ice poss en of et1oe ss ithoni inducement or en elemnent nt force.
imaurt, deeet. slistm’e’. ‘rans other tone ofeomistraint oreoereon,
‘l’le Ford ,umd Drue .-Blnnum’tm’amion F[),-\ 1 mandates eight basic
elements of ntormed consent: m’eseareft procedures. risks and di’s-
comforts, benefits, ahernittive treatments, compensation, confiden
tiality, the voluntary nature of subject participation, and contacts,5
‘[‘he consent form is merely the docimentati on of infornted
eonent and does ttot. n and ot ttself. constitute mnl’onmed: eom’semtt,
‘the fact that a srthject ‘,in’d a consent torn does mtot mean flint he.’
she under’mood ss hat ‘s as hems aem’eed to or trul’s vase their volun
iar\ consent, One problem ss’itt’m int’onmned consent mx information
ove.rk.nid, which can eattse. increase.d stress, confut.; iou, annd impaire.d
decision-making. Potential p:trticipants who hi’s e information
i’s enload cannot s at irtt svha t is upon ant t’m’om what is not i nipor
taut. Ihe :aem’agt’ person camm juggle only three to live pieces of
mnfom’im’iation at otic tin’ie: potential partcmpmts must process a utmie
amount of mnformat h tm,
Prior to participating in a clintcal trial or any research study’,
investigators are reqm.tired to provide subjects with information so
that they ‘ an make rtn informed decisiort about participating in a
studr before the stndr is initiated. Informed consent implie5 that
simhtects has e been vms cmi complete mniimnllatuon about the studr ,that’
they eompm’ehend the explanatiomm. and that they are s’oli.mtmteerine to
[‘i’t icip:mte in the st udr based u pin this tmttderstat mdman. Them m uu’st
also rtndentand they can withdraw from the study at any time. ‘[‘he
informed consent document is ‘nly one part of an ongoing process
of nlormed consent lint starts before a participant goes on study.
amid continues ti’ouchout study Participation amid often thm’ontch
Ii osv - u,
ylitnx’ people ss’no sne being recruited ton clinical trmals and ‘them
cancer research studies are sick: they mar he stressed, depressed,
and. fearfu.l, A I 996 study shosve.d how disease i..’e.verity aff”e.ets
n’fomnxed ionsetit unde.rstandi.ng. HeaIthm: voiunte.ens retnemhere’d
the most ahoitt risks and side effects, svhi i.e severelr ill patients in
I studIes r’emm’iemrhet’ed the least,’
,\ppelhatiue.t al tonnd that mi’m:’inm” sutiject.s thotmgltt the ncseai’ch
ss ould benefit tltemn, despttc svttat tImer ss’em’e told atid read in
their consents,5”’ Gotay fOund in a large pt’ostate. cancer iNevention
st.ud, thitt. ir.any men did not remcm.he.r the consent process. The.
resntlts of a sluc.t’.’itionnaire m..a.iled to the hcaltl’t ps’trtic’iprttits.’:’ itxd ieated
that the ‘if’orn’ed eonent p’e’ mnrtst he rem nt’oreed ihi’ouehout the
iii “c’ ii, m’n:mmuaim’i c’Omltf”iiattcc’.’
‘lie int’mnmticd onsc!it l.)i’oeess should include adielov’uc betssemi
hoc stti,tetor and potenmi,,d research pam’tieipamtts. Porc’mttiai pamti;l—
pant.s should he. alioss ed to rev iesv the c.omtsetxt ‘form and. ittik’. stues —
tk.nts. Although ixoten.t;ial pam’tieipan.ts ru;e encouraTed t.o ask ques
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[ions, many people are afraid to ask questions because they do not
know what to ask or they do not want to appear dumb, To avoid this.
the subteets should take the consent documents home to read and
v rite their questions on the consent form. They should be encour—
aced to highlight areas the do not understand, When the “uhiect’.
return with the consent form. the in’s estigator should answ ci all
questions and concerns that the potential participants have, to ensure
that the richts of the participant are protected
The National Cancer Institute’s \Cl mission has alwa in
cluded the ethical conduct of cancer clinical trials s ith an emphasis
on informed coilsent. Though conseni lorms are supposed to help
subjects make well—informed decisions, because of concerns o\ er
meeting legal requirements. the conseni forms in NCI—cponsored
clinical trials have become er complex. very long, and verx
diftieult to read and understand.
In late 1995, a working group of experts. which included lRl3
members, clinical investigators, nurses, patient advocates, lawyers.
ethicists, communication experts. members of the pharmaceutical
industry, and staff from OHRP, FDA, and NCI met to discuss
problems with the informed consent process. This group of experts.
named the Comprehensive Working Group, was asked to recomn
mend improvements to the informed consent and quality of consent
torms. The group worked diligentl for over two years.
In September 1998, the Comprehensive Working Group pub
lished a template called Reconunendations for Developing In—
formed Consent Documents for Cancer Clinical Trials:
The general recommendations included suagestions about for
matting. readability and specific elements of informed consent. The
group also suggested writing consents at an eighth grade reading
level. However, even at a sixth grade reading level, a consent form
is difficult to understand because most people are not familiar \\ ith
research procedures. The recommendations have been supported b
a letter from ()HRP, a Special Award for Plain Speaking in Govern—
tnenl from ‘vice President Gore’s\ ational Partnership to Re—Invent
Government in 2000, andan NIH award forPlain Speaking in 2001
Now. more than a half a cen1ur since the Nuremherg trials, new
ethical issues have appeared on the horizon of medical research. In
particular, consent issues with children have surfaced, Children are
considered a vulnerable population at risk for exploitation; there
fore. they are given special protection in clinical research* At the
same time, research on children is sorely needed to understand more
about pediatric diseases and improse health care for children, Both
parental agreement plus a child’s “assent” are needed for a child to
participate in research,
In 1—Iawai i, before research studies are initiated, the [ni versi t\
andior hospital IRBs re tess each studs ‘s desien and cou’ent
procedures and forms. An IR 13 i’. comprised of men and omen.
‘ ho ha e the professional competene\ necessary to review specific
research activities, Each [RB must include at least one member
ss hose prim’y concerns are in scientitic a i-c as. one member in a
nonscientific area, and at least one member who is a eonlniunit\
person not atfiliated with the institution . The IRK is responsible lr
sateguatyling the richts and \k el tare ol human subjects in researe
This includes compl\ ing ith federal and local regulations and
ethical principles.
II an IR[3 regularly re\ iev s research that involves vulnerable
subjects, such as children. prisoners, pregnant women, or handi
capped o 11 ntall\ disabled 1S oic r 11101 ii di idual-. mu
be includ d on thL hou d v ho ai knos I d ahl nd C\ll ‘i icn
in ‘.s oi kit s ith these suhiecis.
In suininars intormed consent is a p105 not sinele s\
ieqnnes he tith jmlessionals to hoe ‘p ‘ t 511055 Is’dg” nsl
conlmtnli5atmon skill-. \\ ith the5omplexmt ‘. eineci mesc,treh. sn
as potential -.hort- and lone-ici in io\imiie’ n e,itilleni. ii resl Ii
ins esto ,ttoi s to continue ill5 pioss-. ih,ougi ut rh iue\
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Questions,
Anyone?
Get answers you can
trust about federal gov
ernment programs, ben
efits, and services from
the Federal Consumer
Information Center, We’ll
answer your questions
directly or get you to
the person who can.
Just call toll-free:
1 -800-FED-INFO
(That’s 1-800-333-4636)
Mon-Fri 8am-8pm ET
Or visit:
www.pueblo.gsa.gov/caII
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